Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
The Startup’s Guide: 10 Must-Have CMC SOPs for Virtual Pharma in Phase 1
Read More
white-paper
The CMC Trap: How Chemistry, Manufacturing, and Controls Failures Derail Drug Development
Read More
post
FDA PreCheck Pilot: A Smarter, Infrastructure-Centered Alternative to Fast Track and Breakthrough Designations
Read More
infographic
The Business Case for Investing in CMC: Protecting Your Asset and Ensuring Success
Read More
Let's move from science to success.
Let’s Talk